Rallybio Corporation (RLYB) Tops Q3 EPS by 9c
Tweet
Share
E-mailGet Alerts RLYB Hot Sheet
Join SI Premium – FREE
Rallybio Corporation (NASDAQ: RLYB) reported Q3 EPS of ($0.26), $0.09 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $299 thousand versus the consensus estimate of $75 thousand.
For earnings history and earnings-related data on Rallybio Corporation (RLYB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Downgrades Core Natural Resources (CNR) to Neutral
- Jack Henry (JKHY) Tops Q4 EPS by 13c
- Keysight Technologies (KEYS) Tops Q3 EPS by 59c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
